Previous Close | 41.25 |
Open | 40.29 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 40.29 - 41.57 |
52 Week Range | 28.80 - 44.61 |
Volume | |
Avg. Volume | 62,695 |
Market Cap | 37.883B |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | 37.08 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.56 (1.34%) |
Ex-Dividend Date | Jan 04, 2024 |
1y Target Est | N/A |
COSTA MESA, Calif., May 07, 2024--Healthcare providers and patients are in rare agreement that healthcare access and service-levels are improving, according to the Experian Health 2024 State of Patient Access survey. Almost a third (28%) of patients and 55 percent of providers surveyed say the environment is getting better while patients still say the top challenge is seeing a practitioner quickly.
COSTA MESA, Calif., April 17, 2024--Lack of financial knowledge is leading to costly financial missteps for many Americans according to new research released today by Experian®.
COSTA MESA, Calif., April 16, 2024--Experian announced that the company was named a Leader in the IDC MarketScape: Worldwide Enterprise Fraud Solutions 2024 Vendor Assessment (doc #US51939124, March 2024). The report evaluates each vendor’s advanced fraud detection capabilities, alignment with customer needs, and future strategy and roadmap for innovation.